Evidence map›Paper›PMID 42367949›Full record

ArticlebioRxiv : the preprint server for biology2026

Beatriz Maio, Aditi Singh, Ralph Hector, Kamal Gadalla, Jim Selfridge, Francesca Aria, Susana R Louros, Stuart R Cobb, Emily K Osterweil

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Beatriz MaioRosamund Stone Zander and Hansjoerg Wyss Translational Neuroscience Center, Boston Children's Hospital, Boston, MA, USA.
Aditi SinghRosamund Stone Zander and Hansjoerg Wyss Translational Neuroscience Center, Boston Children's Hospital, Boston, MA, USA.
Ralph HectorCentre for Discovery Brain Sciences, Simons Initiative for the Developing Brain, University of Edinburgh, UK.
Kamal GadallaCentre for Discovery Brain Sciences, Simons Initiative for the Developing Brain, University of Edinburgh, UK.
Jim SelfridgeCentre for Discovery Brain Sciences, Simons Initiative for the Developing Brain, University of Edinburgh, UK.
Francesca AriaRosamund Stone Zander and Hansjoerg Wyss Translational Neuroscience Center, Boston Children's Hospital, Boston, MA, USA.
Susana R LourosCentre for Discovery Brain Sciences, Simons Initiative for the Developing Brain, University of Edinburgh, UK.
Stuart R CobbCentre for Discovery Brain Sciences, Simons Initiative for the Developing Brain, University of Edinburgh, UK.
Emily K OsterweilRosamund Stone Zander and Hansjoerg Wyss Translational Neuroscience Center, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0003-0582-2284

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
NICHD NIH HHS P50 HD105351Wellcome Trust
6 · The paper itself

Abstract

Fragile X syndrome (FXS) is a neurodevelopmental disorder associated with auditory hypersensitivity, circuit hyperexcitability, and seizures. Whether re-expression of the

Indexed as

audiogenic seizuresFMR1Fragile X syndromegene therapyinferior colliculusNpas4

Identifiers

PMID42367949
PMCPMC13308162

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.